Patient Reported Outcomes Burdens and Experiences - Phase 3

Sponsor
McMaster University
Study ID
NCT03549858
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

  • Quality of life measure (survey) — OTHER
    The QoL tool is a questionnaire

Study Details

The PROBE Phase-3 study will collect data on patient reported outcomes, burdens, and experiences in patients living with hemophilia. The investigators will perform comparisons among countries, within country over time, within country against national normative data.

Key Dates

First listed
Jun 8, 2018
Start date
Jan 1, 2018
Status verified
Aug 2025
Primary completion
Dec 31, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
1,000 participants (estimated)

Primary Outcome Measure

Between-countries variability of the PROBE score [ Time Frame: 2 years ]

Central Contacts

Related Studies